Trial Design

Parents of children with cancer and limited health literacy were associated with lower comprehension of informed consent.

Webinar Date/Time: Tuesday, February 6th, 2024 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Women within underserved populations with an endometrial, ovarian, or cervical cancer diagnosis were found to be underrepresented in trials.

V940 (mRNA-4157) to be evaluated in combination with Keytruda (pembrolizumab) as an adjuvant treatment for patients with completely resected Stage II, IIIA, or IIIB non-small cell lung cancer.

Recent study proposes consensus-based extension to the Consolidated Standards of Reporting Trials 2010 Statement for factorial trials.

How novel clinical trial designs can help minimize patient burden.

While still in its infancy, generative AI will continue to be integrated into clinical operations.

Despite regulatory guidance, disability status is frequently unreported or overlooked in trial design.

Results from decade-long analysis suggest great improvement is needed in the quality of control groups.

There is a growing need to refocus efforts on how diversity is achieved in clinical trials, because some are doing it wrong despite their best intentions.

In the ever-evolving landscape of healthcare, it's vital for organizations to take steps toward bridging the gap between their clinical and marketing teams.

Webinar Date/Time: Thursday, November 30th, 2023 at 3pm EST | 12pm PST | 8pm GMT | 9pm CET

Webinar Date/Time: Tue, Nov 14, 2023 11:00 AM EST

Webinar Date/Time: Thursday, November 2nd, 2023 at 10am EDT | 7am PDT | 2pm GMT | 3pm CET

Webinar Date/Time: Wednesday, November 8th, 2023 at 11am EST | 8am PST | 4pm GMT | 5pm CET

Experts weigh in on the latest advances and adoption trends.

Approaching protocol design and operational planning with patient empathy.

Webinar Date/Time: Wed, Sep 20, 2023 10:00 AM EDT

In this Q&A, Matt Smith, Vice President Research Site Development, Slope discusses the competition pharma companies and trial sponsors face when trying to become a sponsor of choice and build trust with sites and patients.

Perceived barriers of DCTs can be quickly overcome to ensure their viability in clinical research.

Eko Health developed the device, which has received 501(k) clearance from the FDA.

Webinar Date/Time: Thursday, June 22nd, 2023 at 9am EDT | 6pm PDT | 2pm BST | 3pm CEST